You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 8,853,493


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,853,493
Title:Virus induced gene silencing (VIGS) for functional analysis of genes in cotton
Abstract: The invention relates to the functional analysis of genes in cotton by employing the Virus Induced Gene Silencing (VIGS) method. More specifically this method induces gene silencing in cotton with the help of the Tobacco Rattle Virus (TRV) vectors RNA1 and RNA2 and phenotypic effects on the cotton plant can be analysed Moreover this invention also provides transient expression vector TRV RNA2 in order to transiently express genes in cotton plants and plant tissue under the influence of a strong subgenomic promoter.
Inventor(s): Ye; Jian (Singapore, SG), Chua; Nam Hai (Singapore, SG), Qu; Jing (Singapore, SG), Geng; Yun Feng (Singapore, SG), Bu; Yun Ping (Singapore, SG)
Assignee: Temasek Life Sciences Laboratory Limited (Singapore, SG)
Application Number:13/376,902
Patent Claims:1. A method of virus-induced gene silencing (VIGS) in cotton comprising: (a) inserting a nucleic acid comprising a first silencing sequence capable of silencing a first desired gene into a vector comprising a tobacco rattle virus (TRV) RNA2 sequence to produce a vector comprising a modified TRV RNA2 sequence; (b) preparing a mixed culture of Agrobacterium comprising Agrobacterium containing a vector comprising a modified TRV RNA1 sequence and Agrobacterium containing the vector comprising the modified TRV RNA2 sequence, wherein the modified TRV RNA1 sequence is a TRV RNA1 sequence into which an intron has been inserted, wherein the insertion is within positions corresponding to 10919-10922 of SEQ ID NO: 1; (c) introducing the mixed culture of Agrobacterium into plant tissue of cotton to produce infected plant tissue; and (d) growing the infected plant tissue for a sufficient to produce systemic TRV infection in the infected plants and to thereby induce gene silencing of the first desired gene.

2. The method of claim 1, wherein the vector comprising TRV RNA2 and the vector comprising TRV RNA1 are synthetic plant vectors.

3. The method of claim 1, wherein the first silencing sequence is a sequence of a sense strand of the first desired gene.

4. The method of claim 1, wherein the first silencing sequence is a sequence of an antisense strand of the first desired gene.

5. The method of claim 1, wherein the first silencing sequence encodes a short hairpin RNA (shRNA) or a precursor microRNA (miRNA).

6. The method of claim 1, wherein the nucleic acid further comprises a second silencing sequence capable of silencing a second desired gene.

7. The method of claim 1, wherein the nucleic acid comprises multiple silencing sequences capable of silencing multiple desired genes.

8. The method of claim 1, wherein the desired gene is a candidate transcription factor gene.

9. The method of claim 1, wherein the desired gene is a candidate gene in smRNA biosynthesis.

10. The method of claim 1, wherein the desired gene is selected from the group consisting of (a) a candidate gene in a proanthocyanidin or anthocyanidin biosynthetic pathway, (b) a candidate gene in cotton fiber development, (c) a candidate gene in a chlorophyll or arotenoid biosynthetic pathway and (d) a candidate gene in a flavonoid biosynthetic pathway.

11. The method of claim 10, wherein the candidate gene in cotton fiber development is a candidate gene in cotton fiber initiation, elongation, secondary wall deposition, maturation or seed development.

12. The method of claim 1, wherein the cotton tissue is a cotton plant, a cotton seedling, a cotton ovule or cotton fiber.

13. The method of claim 1, wherein the cotton is a diploid variety, a tetraploid variety, a variety of an inter-species cross or a variety of an interspecies cross.

Details for Patent 8,853,493

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2039-02-26
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2039-02-26
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2039-02-26
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.